Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reirradiation and hyperthermia with or without cisplatin for locally recurrent breast cancer
NL-OMON34632Phase 2Not yet recruiting
- Sponsor
- Amsterdam UMC
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin in breast cancer (2 arms), sponsored by Amsterdam UMC. Primary endpoint: Local control rate. Planned start Feb 2011; status: not yet recruiting.
02
Drugs
cisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON34632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34632.